These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35144993)

  • 1. Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation.
    Olsson KM; Richter MJ; Kamp JC; Gall H; Ghofrani HA; Fuge J; Ewert R; Hoeper MM
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35144993
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation.
    Waligóra M; Kopeć G
    Kardiol Pol; 2022; 80(11):1167-1168. PubMed ID: 36463573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolution of Risk Assessment in Pulmonary Arterial Hypertension.
    Murthy S; Benza R
    Methodist Debakey Cardiovasc J; 2021; 17(2):134-144. PubMed ID: 34326933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?
    Rosenzweig EB; Bacha E
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1150-1151. PubMed ID: 33334602
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung Transplantation for Pulmonary Arterial Hypertension.
    Kolaitis NA
    Chest; 2023 Oct; 164(4):992-1006. PubMed ID: 37150504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
    Ford HJ; LeVarge B
    Chest; 2021 Jan; 159(1):14-16. PubMed ID: 33422195
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
    Humbert M; Lau EMT
    Am J Respir Crit Care Med; 2021 Mar; 203(6):675-677. PubMed ID: 33357026
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
    Pausch C; Pittrow D; Hoeper MM; Huscher D
    Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37802633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
    Fauvel C; White RJ; Vanderpool RR; Badagliacca R; Tobore T; Rahman M; Vizza CD; Lin S; Everett AD; Visovatti SH; Benza RL
    Chest; 2024 Feb; 165(2):431-436. PubMed ID: 37709252
    [No Abstract]   [Full Text] [Related]  

  • 10. The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
    Haarman MG; Douwes JM; Ploegstra MJ; Roofthooft MTR; Vissia-Kazemier TR; Hillege HL; Berger RMF
    Am J Respir Crit Care Med; 2019 Nov; 200(10):1312-1315. PubMed ID: 31298925
    [No Abstract]   [Full Text] [Related]  

  • 11. Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.
    Richter MJ; Tello K
    Am J Respir Crit Care Med; 2020 Feb; 201(4):403-405. PubMed ID: 31726011
    [No Abstract]   [Full Text] [Related]  

  • 12. Gaps of evidence in pulmonary arterial hypertension.
    Vizza CD; Ghio S; Badagliacca R; Manzi G; Scelsi L; Argiento P; D'Alto M
    Int J Cardiol; 2022 Oct; 364():119-123. PubMed ID: 35716936
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Stratification and Treatment for Pulmonary Arterial Hypertension. Gaps and Promising Remedies.
    Del Pozo R; Cruz-Utrilla A; Escribano-Subias P
    Arch Bronconeumol; 2023 Oct; 59(10):617-618. PubMed ID: 37147267
    [No Abstract]   [Full Text] [Related]  

  • 14. The Oracle of the Auricle?: Optimizing Serial Risk Stratification of Patients With Pulmonary Arterial Hypertension.
    Shelburne NJ; Frantz RP
    Chest; 2022 Sep; 162(3):509-510. PubMed ID: 36088091
    [No Abstract]   [Full Text] [Related]  

  • 15. [Risk stratification methods and their significance in pulmonary arterial hypertension].
    Avdeev SN; Tsareva NA
    Ter Arkh; 2019 Sep; 91(9):150-157. PubMed ID: 32598827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
    Frantz RP; Swift AJ
    Chest; 2024 Jan; 165(1):12-13. PubMed ID: 38199727
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung transplantation and atrial septostomy in pulmonary arterial hypertension.
    Norfolk SG; Lederer DJ; Tapson VF
    Clin Chest Med; 2013 Dec; 34(4):857-65. PubMed ID: 24267309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
    Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
    Benazzo A; Bajorek L; Morscher A; Schrutka L; Schaden E; Klepetko W; Hoetzenecker K;
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):524-535.e3. PubMed ID: 34144824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging risk in pulmonary arterial hypertension.
    Badagliacca R; Vizza CD
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32973075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.